RxDoctor Payments DataLook up a doctor →

Ashley Klisz, NP

Nurse Practitioner · Ann Arbor, MINPI 1225421373

Payments from drug & device makers

$18,779in general payments, 2019–2025

Across 814 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • EMD Serono, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • UCB, Inc.$1K
  • AbbVie$1K
  • Nalu Medical, Inc.$978
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis140$2,360
EMD Serono, Inc.45$1,249
Teva Pharmaceuticals USA, Inc.35$1,054
UCB, Inc.66$1,015
AbbVie(2 entities)64$1,013
Nalu Medical, Inc.2$978
Nevro Corp.9$977
Neurelis, Inc.23$617
Sanofi15$574
Pfizer33$514
Biogen22$511
AstraZeneca(2 entities)25$500
Bristol Myers Squibb33$496
Alnylam Pharmaceuticals Inc.29$486
Lundbeck LLC16$459
TG Therapeutics, Inc.16$440
Neurocrine Biosciences, Inc.19$438
Axsome Therapeutics, Inc.8$354
Lilly USA, LLC20$334
Otsuka America Pharmaceutical, Inc.13$330
Argenx US, Inc.15$316
Acadia Pharmaceuticals Inc12$312
SK Life Science, Inc.7$266
Amgen(2 entities)7$250
Takeda Pharmaceuticals U.S.A., Inc.15$246
Eisai Inc.8$191
CSL Behring10$186
Sumitomo Pharma America, Inc.9$173
Genentech USA, Inc.8$171
Johnson & Johnson9$166
Biohaven Pharmaceuticals, Inc.4$161
Kyowa Kirin, Inc.8$157
Scilex Pharmaceuticals Inc.7$144
ANI Pharmaceuticals, Inc.7$124
Jazz Pharmaceuticals Inc.7$116
Amneal Pharmaceuticals LLC4$97
E.r. Squibb & Sons, L.L.C.2$92
GRT US Holding, Inc.2$91
Acorda Therapeutics, Inc3$79
Vanda Pharmaceuticals Inc.3$78
Catalyst Pharmaceuticals, Inc.3$68
Cycle Pharmaceuticals Inc2$54
Octapharma USA, Inc.2$52
Sunovion Pharmaceuticals Inc.3$47
Azurity Pharmaceuticals, Inc.3$44
Mallinckrodt Hospital Products Inc.2$37
Hospira, Inc.2$31
Avadel CNS Pharmaceuticals, LLC1$30
Averitas Pharma Inc.1$26
Grifols USA, LLC1$24
Tanabe Pharma America, Inc.1$23
Validus Pharmaceuticals LLC1$23
Otsuka Pharmaceutical Development & Commercialization, Inc.1$22
Harmony Biosciences LLC1$20
Biohaven Pharmaceutical Holding Company Ltd.1$20
Corium, LLC1$19
Cala Health, Inc.1$18
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$18
Xeris Pharmaceuticals, Inc.1$18
Livanova USA, Inc.1$16

How this compares

$18,779 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan →

Medicare billing

Part B allowed, 2024
$13,644
Medicare patients
78
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Ann Arbor

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →